Condition
Obstructed Defecation Syndrome (ODS)
Total Trials
3
Recruiting
0
Active
0
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 75/100
Termination Rate
33.3%
1 terminated out of 3 trials
Success Rate
50.0%
-36.6% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results50% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 2 (1)
Trial Status
Completed1
Terminated1
Not Yet Recruiting1
Trial Success Rate
50.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT07039188Not ApplicableNot Yet Recruiting
Clinical Evaluation of the Femiset Device for Perineal Descent in Women
NCT02160288Phase 2TerminatedPrimary
Effects of Botox in Obstructed Defecation Syndrome
NCT00587080CompletedPrimary
Stapled TransAnal Rectal Resection (STARR): Clinical and Radiological Outcome
Showing all 3 trials